Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2017.10.081
Abstract: Typhoid fever remains a serious public health problem with a high impact on toddlers and young children. Vaccines against the Vi capsular polysaccharide are efficacious against typhoid fever demonstrating that antibodies against Vi confer protection.… read more here.
Keywords: vaccine; typhoid fever; gelsite oac;